1.1 Class members
Benzodiazepine | Licensed indications* | Formulations | Strengths |
---|---|---|---|
alprazolam | Moderate to severe anxiety states; anxiety associated with depression | Tablets | 250 micrograms, 500 micrograms |
chlordiazepoxide | Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal | Tablets | 5 mg, 10 mg |
clobazam | Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy | Tablets | 10 mg |
clonazepam | Epileptic disease | Tablets | 500 micrograms, 2 mg |
Status epilepticus | Injection | 1 mg/ml: 1 ml | |
diazepam | Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treatment of epilepsy; alcohol withdrawal; premedication before dental procedures or before surgery | Tablets | 2 mg, 5 mg, 10 mg |
Oral solution | 2 mg/5 ml, 5 mg/5 ml | ||
Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens) | Injection solution | 5 mg/ml: 2 ml | |
Injection emulsion | 5 mg/ml: 2 ml | ||
Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures | Rectal solution | 2 mg/ml: 1.25 ml, 2.5 ml | |
flurazepam | Disabling or unacceptably distressing insomnia | Capsules | 15 mg, 30 mg |
loprazolam | Disabling or unacceptably distressing insomnia | Tablets | 1 mg |
lorazepam | Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery | Tablets | 1 mg, 2.5 mg |
Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus | Injection | 4 mg/ml: 1 ml | |
lormetazepam | Disabling or unacceptably distressing insomnia | Tablets | 500 micrograms, 1 mg |
midazolam | Acute prolonged convulsive seizures | Oromucosal solution | 5 mg/ml: 0.5 ml, 1 ml, 1.5 ml, 2 ml |
Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care | Injection | 1 mg/ml: 2 ml, 5 ml, 10 ml | |
nitrazepam | Disabling or unacceptably distressing insomnia | Tablets | 5 mg |
Oral suspension | 2.5 mg/5 ml | ||
oxazepam | Disabling or unacceptably distressing anxiety | Tablets | 10 mg, 15 mg |
temazepam | Disabling or unacceptably distressing insomnia; premedication before medical procedures | Tablets | 10 mg, 20 mg |
Oral solution | 10 mg/5 ml | ||
*Consult summaries of product characteristics for up to date statements on authorised indications |